A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility

Fertility and Sterility

Volumn 77, Issue 1, 2002, Pages 91-97

  Imani, Babak ^a   Eijkemans, Marinus J C ^a   Te Velde, Egbert R ^b   Fauser, Bart C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anovulation; Clomiphene citrate; Female; Follow up studies; Human; Induction of ovulation; Infertility; Polycystic ovary syndrome; Prediction

Indexed keywords

ANDROGEN; CLOMIFENE CITRATE; FOLLITROPIN; GLOBULIN; SEX HORMONE; TESTOSTERONE;

ADULT; AGE; AMENORRHEA; ANOVULATION; ARTICLE; BODY MASS; CHILDBIRTH; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; FEMALE; GONAD; HUMAN; INFERTILITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MODEL; NOMOGRAM; OVULATION INDUCTION; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; SCREENING; TREATMENT INDICATION;

ABORTION, SPONTANEOUS; AMENORRHEA; CLOMIPHENE; EJACULATION; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFANT, NEWBORN; INFERTILITY, FEMALE; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; ODDS RATIO; OLIGOMENORRHEA; OVULATION; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; RETROSPECTIVE STUDIES; SPERM COUNT; TREATMENT OUTCOME;

EID: 0036150917     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)02929-6     Document Type: Article

References (22)

1. Induction of ovulation with MRL/41
2. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility
3. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility
4. Further clinical experience with clomiphene citrate
5. Ovulation and pregnancy rates with clomiphene citrate
6. Relationship of weight to successful induction of ovulation with clomiphene citrate
7. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation
8. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: The difference between responders and nonresponders
9. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment
10. Modern use of clomiphene citrate in induction of ovulation
11. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility
12. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle
13. How to discriminate between normal and polycystic ovaries: Transvaginal US study
14. Classification of normogonadotropic infertility: Polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome
15. Nonparametric estimation from incomplete observations
16. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease
17. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age
18. Serum leptin concentrations in women with polycystic ovary syndrome
19. The insulin-related ovarian regulatory system in health and disease
20. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation
21. Elevated serum levels of free insulin-like growth factor-1 (IGF-1) in polycystic ovary syndrome